[Pharmacokinetics of nifedipine after a single oral dose in patients with disorders of cerebral circulation]. 1989

M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian

The pharmacokinetics of nifedipine was studied in 44 patients with disorders of cerebral circulation. A significant variability of the pharmacokinetic parameters in different patients was revealed. According to the results of the cluster-analysis, the main types (classes) of nifedipine pharmacokinetics were established and the possibility of regarding the patient examined as having this or that type during the measurement of the blood nifedipine concentration 2, 3 and 4 hours after administration of the drug was shown. The relationship between the type of nifedipine pharmacokinetics and its antiaggregatory effect was established.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1990, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1986, Farmakologiia i toksikologiia,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1990, European journal of clinical pharmacology,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
May 1982, British journal of clinical pharmacology,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
April 1992, British journal of clinical pharmacology,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1995, European journal of drug metabolism and pharmacokinetics,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1988, International journal of clinical pharmacology research,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1975, The Journal of clinical endocrinology and metabolism,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 1990, European journal of drug metabolism and pharmacokinetics,
M A Sarkissian, and S E Akopov, and G S Grigorian, and A A Ordukhanian, and A G Panosian
January 2005, Drugs under experimental and clinical research,
Copied contents to your clipboard!